Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

Facebook is the latest social media platform to give users greater control over the algorithm that determines what appears in their feeds. Meta announced the launch of its new AI-powered feature, ...

Meta’s bringing Instagram’s “Your Algorithm” feature to Facebook, and using LLMs more to rank content. Meta’s bringing Instagram’s “Your Algorithm” feature to Facebook, and using LLMs more to rank ...

Recommendation algorithms promise social media users a personalized experience, but some experts worry they promote doomscrolling, brain rot, and myriad mental health problems. Australia recently ...

“[The IRS] is using AI to identify targets for who’s going to be audited,” Rob Kovacev, a tax lawyer at Miller & Chevalier, told Inc. “They’re doing that at all levels, for everything—from small ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...

Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...